| Size & multiples | |||
| Market Cap | $770.5M | Enterprise Value | — |
| P/E (TTM) | — | PEG (trailing) | — |
| P/S | 15.90× | P/FCF | — |
| EV/EBITDA | — | EV/EBIT | — |
| EV/Sales | — | EV/FCF | — |
| FCF Yield | −2.28% | Buyback Yield | — |
| Owner Earnings (TTM) | -$10.0M | Owner Earnings Yield | −1.30% |
| Shareholder Yield | — | ||
| Cost of capital & EVAmethodology → | |||
| Beta (5y monthly) | 0.17 | Risk-free (assumed) | 4.00% |
| Equity risk premium (assumed) | 5.00% | Cost of Equity | 4.83% |
| After-tax Cost of Debt | — | WACC | — |
| ROIC | — | EVA Spread (ROIC−WACC) | — |
| EVA | — | ||
FCF sits 75% below owner earnings — spending above maintenance (growth capex) or absorbing working capital, so FCF understates the steady-state cash the business throws off.
Flows TTM (last 4 quarters); latest annual for: EPS (Diluted) · EPS TTM -$0.06 · revenue TTM $48.5M · FCF TTM -$17.6M
Output of a disclosed model whose assumptions may be wrong — research information, not investment advice. See the Disclaimer.
Compared against all 1054 Health Care names we cover — one sector-wide pool, so the median skews toward smaller (often unprofitable) companies. Try the Size band for a cap-matched read.
| Metric | This (FY) | Peer median | IQR (25–75) | %ile |
|---|---|---|---|---|
| FCF Yield | -2.9% | -7.9% | -35.6%–1.4% | 61 ↑strong |
| Net Margin | -28.5% | -21.2% | -325.3%–7.2% | 48 ↓weak |
| Operating Margin | -19.3% | -34.5% | -552.0%–8.0% | 54 ↑strong |
| ROE | -46.9% | -36.8% | -92.5%–4.5% | 44 ↓weak |
